Zenas BioPharma, Inc. (ZBIO)

NASDAQ: ZBIO · Real-Time Price · USD

39.38

+1.27 (3.33%)

At close: Dec 5, 2025, 4:00 PM EST

39.98

+0.60 (1.52%)

After-hours: Dec 5, 2025, 6:51 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Immune-based Therapies	5.00M	Log In
Immune-based Therapies Growth	-90.00%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	5.00M	Log In
United States Growth	-90.00%	Log In